Abstract
In pediatric patients, most widely used imaging tools are ultrasonography, magnetic resonance imaging, fluoroscopy, and computed tomography, respectively. Each of these modalities requires contrast materials compatible with the modality and imaging goal. Nevertheless, all available contrast agents have some disadvantages. One should keep in mind that the children are not small adults and they are more vulnerable regarding the adverse effects of contrast material administration. Multiple parameters such as laboratory test results and coexisting diseases should be considered while utilizing contrast materials. Parameters such as creatinine change with the body weight and age, and this need to be kept in mind while evaluating the renal and hepatic functions of the patients. Contrast agent-dependent osmotic load has a more dramatic effect in pediatric patients compared to adults. A low osmolality contrast agent may mean a high osmolality for pediatric patients. Herein, we review the features, adverse effects, and indications of contrast agents in pediatric radiology practice.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Callahan MJ, Talmadge JM, MacDougall RD, Kleinman PL, Taylor GA, Buonomo C. Selecting appropriate gastroenteric contrast media for diagnostic fluoroscopic imaging in infants and children: a practical approach. Pediatr Radiol. 2017;47(4):372–81. https://doi.org/10.1007/s00247-016-3709-5. Epub 2016 Oct 10.
Erdogan N. Radyolojik kontrast maddeler ve aşırı duyarlık tepkimeleri. In: Balci P, Pabuscu Y, editors. Temel radyoloji fiziği. 2008.
Harris PD, Neuhauser EB, Gerth R. The osmotic effect of water soluble contrast media on circulating plasma volume. AJR Am J Roentgenol. 1964;91:694–8.
Johansen JG, Kolmannskog S. Osmotic effect and solubility of amipaque (metrizamide) in the gastrointestinal tract. Invest Radiol. 1978;13(632053):93–7.
Cohen MD. Choosing contrast media for the evaluation of the gastrointestinal tract of neonates and infants. Radiology. 1987;162:447–56.
Poole CA, Rowe MI. Clinical evidence of intestinal absorption of Gastrografin. Radiology. 1976;118(1244649):151–3.
Rowe MI, Seagram G, Weinberger M. Gastrografin-induced hypertonicity. The pathogenesis of a neonatal hazard. Am J Surg. 1973;125(4687998):185–8.
Cohen MD. Safe use of imaging contrast agents in children. J Am Coll Radiol. 2009;6:576–81.
Contrast media in children ACR manual on contrast media—version 10.3/May 31, 2017.
Frech RS, Davie JM, Adatepe M, Feldhaus R, McAlister WH. Comparison of barium sulfate and oral 40 percent diatrizoate injected into the trachea of dogs. Radiology. 1970;95(5439432):299–303.
Friedman BI, Hartenberg MA, Mulroy JJ, Tong TK, Mickell JJ. Gastrografin aspiration in a 3 3/4-year-old girl. Pediatr Radiol. 1986;16(3774397):506–7.
McAlister WH, Siegel MJ. Fatal aspirations in infancy during gastrointestinal series. Pediatr Radiol. 1984;14(6728539):81–3.
Soares BP, Lequin MH, Huisman TAGM. Safety of contrast material use in children. Magn Reson Imaging Clin N Am. 2017;25:779–85.
Peachell PT, Morcos SK. Effect of radiographic contrast media on histamine release from human mast cells and basophils. Br J Radiol. 1998;71(841):24–30.
Dillman JR, Strouse PJ, Ellis JH, Cohan RH, Jan SC. Incidence and severity of acute allergic-like reactions to i.v. non-ionic iodinated contrast material in children. AJR Am J Roentgenol. 2007;188:1643–7.
Shehadi WH. Adverse reactions to intravascularly administered contrast media. A comprehensive study based on a prospective survey. Am J Roentgenol Radium Ther Nucl Med. 1975;124:145–52.
Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsura K. Adverse reactions to ionic and non-ionic contrast media. A report from the Japanese Committee on the Safety of contrast media. Radiology. 1990;175:621–8.
Callahan MJ, Poznauskis L, Zurakowski D, Taylor GA. Non-ionic iodinated intravenous contrast-material related reactions: incidence in large urban children’s hospital-retrospective analysis of data in 12,494 patients. Radiology. 2009;250:674–81.
Rozenfeld MN, Podberesky DJ. Gadolinium-based contrast agents in children. Pediatr Radiol. 2018;48(9):1188–96.
Schwartz GJ, Munoz A, Schneider MF, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009;20(3):629–37.
Callahan MJ, Servaes S, Lee EY, Towbin AJ, Westra SJ, Frush DP. Practice patterns for the use of iodinated IV contrast media for pediatric CT studies: a survey of the society for pediatric radiology. AJR. 2014;202:872–9.
Rigsby CK, Gasber E, Seshadri R, Sullivan C, Wyers M, Ben-Ami T. Safety and efficacy of pressure-limited power injection of iodinated contrast medium through central lines in children. AJR Am J Roentgenol. 2007;188:726–32.
Bhargava R, Hahn G, Hirsch W, Kim MJ, Mentzel HJ, Olsen QE. Contrast-enhanced magnetic resonance imaging in pediatric patients: review and recommendations for current practice. Magn Reson Insights. 2013;6:95–111.
Grobner T. Gadolinium: a specific trigger for the development of nephrogenic fibrosing dermatopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant. 2006;21(4):1104–8.
Marckmann P, Skov L, Rossen K, et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol. 2006;17(9):2359–62.
Nardone B, Saddleton E, Laumann AE, et al. Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR report. Pediatr Radiol. 2014;44(2):173–80.
Roberts DR, Chatterjee R, Yazdani M, Marebwa B, Brown T, Collins HT. Pediatric patients demonstrate progressive T1-weighted hyperintensity in the dentate nucleus following multiple doses of gadolinium-based contrast agent. AJNR Am J Neuroradiol. 2016;37(12):2340–7.
Kanda T, Fukusato T, Matsuda M, et al. Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy. Radiology. 2015;276(1):228–32.
Mc Donald RJ, McDonald JS, Kallmes DF, et al. Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology. 2015;275(3):772–82.
Kanda T, Ishii K, Kawaguchi H, et al. High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1 weighted MR images: relationship with increasing cumulative dose of a gadolinium based contrast material. Radiology. 2014;270:834–41.
Darrah TH, Prutsman-Pfeiffer JJ, Poreda RJ, et al. Incorporation of excess gadolinium into human bone from medical contrast agents. Metallomics. 2009;1:479–88.
Dillman JR, Ellis JH, Cohan RH, Strause PJ, Jan SC. Frequency and severity acute allergic-like reactions to gadolinium containing i.v. contrast media in children and adults. AJR Am J Roentgenol. 2007;189:1533–8.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Özmen, E., Erturk, S.M. (2021). Contrast Agent Use and Safety in Pediatric Patients. In: Erturk, S.M., Ros, P.R., Ichikawa, T., Saylisoy, S. (eds) Medical Imaging Contrast Agents: A Clinical Manual. Springer, Cham. https://doi.org/10.1007/978-3-030-79256-5_20
Download citation
DOI: https://doi.org/10.1007/978-3-030-79256-5_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-79255-8
Online ISBN: 978-3-030-79256-5
eBook Packages: MedicineMedicine (R0)